![dpp4 vs glp 1 The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs | Cardiovascular Diabetology dpp-4_inhibitors [TUSOM | Pharmwiki]](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12933-022-01474-z/MediaObjects/12933_2022_1474_Fig4_HTML.png)
dpp4 vs glp 1
Shipping Estimate
dpp4 vs glp 1 The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs | Cardiovascular Diabetology dpp-4_inhibitors [TUSOM | Pharmwiki]
EUR22.19
EUR49.19
Pay in 4 interest-free payments of $5.55 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
![dpp4 vs glp 1 The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs | Cardiovascular Diabetology dpp-4_inhibitors [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/dpp4.png?w=600&tok=f9724b)
![dpp4 vs glp 1 The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs | Cardiovascular Diabetology dpp-4_inhibitors [TUSOM | Pharmwiki]](https://www.frontiersin.org/files/Articles/464622/xml-images/fendo-10-00389-g0001.webp)
![dpp4 vs glp 1 The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs | Cardiovascular Diabetology dpp-4_inhibitors [TUSOM | Pharmwiki]](https://i.ytimg.com/vi/YRCELHdfGFI/maxresdefault.jpg)
![dpp4 vs glp 1 The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs | Cardiovascular Diabetology dpp-4_inhibitors [TUSOM | Pharmwiki]](https://figures.semanticscholar.org/c15f0327b75d4570d8ee6263ce3f83d7e6f770a3/2-Table1-1.png)
![dpp4 vs glp 1 The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs | Cardiovascular Diabetology dpp-4_inhibitors [TUSOM | Pharmwiki]](https://www.frontiersin.org/files/Articles/464622/fendo-10-00389-HTML/image_m/fendo-10-00389-g003.jpg)
![dpp4 vs glp 1 The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs | Cardiovascular Diabetology dpp-4_inhibitors [TUSOM | Pharmwiki]](https://www.researchgate.net/profile/Sajjad-Ali-33/publication/385525938/figure/fig1/AS:11431281288518357@1730759932978/The-mechanism-of-action-of-GLP-1-analogs-DPP-4-resistant-DPP-4-dipeptidyl.jpg)
:max_bytes(150000):strip_icc()/Wegovy-pill-pic-590ed53ed3304ba8b2388f9d78886dae.png)
